Streptokinase from beta-hemolytic Streptococcus (Lancefield Group C), lyophilized powder, >=3,500 un

Streptokinase from beta-hemolytic Streptococcus (Lancefield Group C), lyophilized powder, >=3,500 un

Stock Code: 3581299
Manufacturer Part No: S3134-50KU
Order Now for 7 day delivery
£238.18 (exc VAT) per EACH
Quantity: - +

Application


Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare. Streptokinase has been used in a study to compare primary coronary intervention and thrombolytic therapy in myocardial infarction patients.


Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare.


General description


Streptokinase from ?-hemolytic Streptococcus, or Streptokinase from Streptococcus hemolyticus, is effective in thrombolytic therapy.


Packaging


10000, 50000, 250000 units in glass bottle


Physical form


Lyophilized powder containing ~50% total protein by biuret and sodium glutamate. Total protein composed of enzyme protein and human serum albumin.


Unit Definition


One unit is equal to the amount of activity in one unit from a Streptokinase International Standard reference vial.

Quality Level200
ManufacturerSIGMA-ALDRICH
Storage Temp.−20°C
Formlyophilized powder

There are no downloads for this product.